Beginning on Jan. 1, the country's largest private insurer will cover the initial follow-up breast exam for beneficiaries with certain plans. 

The Government Accountability Office wrote in a new report that the National Institutes of Health violated the Impoundment Control Act, which bars delays in allocating funds approved by Congress, when it pulled funds for research grants linked to “equity-related” initiatives.

Patients told the PAN Foundation they were helped by charities and manufacturer rebate programs, with some advised by alternative funding programs to get their drugs from outside the country.

Ultromics plans to use the new funds to help expand its presence throughout the United States. In addition, the company is focused on developing additional AI-enabled software offerings.

Karen Joynt Maddox, MD, MPH, explained the many ways cardiology's business models are starting to evolve. She also touched on a number of other topics, including AI and the power of prevention.

The first coronary DCB to gain FDA approval just received an additional reimbursement that could improve patient access. 

The payment program spent $484 million on 15 different low-value imaging services, a figure that balloons to $584 million when factoring for out-of-pocket costs.  

California-based Heartflow, which offers an AI software that assesses coronary CT angiography scans, hopes to raise over $200 million through the stock offering.